<-- Back to petitions
NICE Enhertu Cancer Treatment
P002858 - 18 September 2023
Presentations: 1
Presenters: 1
At a Glance
This petition concerning nice enhertu cancer treatment was presented to Parliament once by 1 MP.
Issue Summary
The petition calls for the National Institute for Health Care and Excellence (NICE) to approve the use of the drug Enhertu for NHS cancer treatment among patients with the HER2 mutation, beyond its current approval for breast cancer only.
Action Requested
NICE should take steps to approve the further use of Enhertu in NHS cancer treatments for patients with the HER2 mutation.
Key Facts
- The petition received over 166,000 signatures.
- Enhertu is currently approved exclusively for breast cancer treatment by NICE.
- In the United States, Enhertu has been approved for patients with the HER2 mutation.
Presentation Timeline
MPs presented this petition on the following dates. Each card shows the presenters and any recorded remarks.
Presented
18 September 2023
Saqib Bhatti
Con
Meriden and Solihull East
Further to the similar change.org petition that received over 166,000 signatures, I formerly present this petition on behalf of my constituent, Elaine Lynch. It calls on the National Institute for Health Care and Excellence to authorise the use of the drug Enhertu for NHS cancer treatment among patients with the HER2 mutation, given that the drug currently holds approval exclusively for breast cancer treatment.
The petition states:
▸
Assessment & feedback
Summary accuracy